Safety and pharmacokinetics of rituximab in combination with FAB chemotherapy in children and adolescents with Stage III/IV mature B-NHL and B-cell leukemia ± CNS disease: a Children's Oncology Group Report

被引：0
|
作者：
Barth, M. J. [1 ]
Goldman, S. [2 ]
Zhi, J. [3 ]
Smith, L. [4 ]
Harrison, L. [5 ]
Perkins, S. L. [6 ]
Shiramizu, B. [7 ]
Gross, T. [6 ,8 ]
Sanger, W. [4 ]
Cairo, M. S. [5 ,9 ,10 ,11 ,12 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[2] Med City Childrens Hosp, Div Pediat Hematol Oncol, Dallas, TX USA
[3] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
[4] Univ Nebraska, Coll Publ Hlth, Dept Biostat, Omaha, NE 68182 USA
[5] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA
[6] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[7] Univ Hawaii, Div Pediat Hematol Oncol, Honolulu, HI 96822 USA
[8] Ohio State Univ, Columbus, OH 43210 USA
[9] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[10] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA
[11] New York Med Coll, Dept Microbiol, Valhalla, NY 10595 USA
[12] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [41] Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)
    Hochberg, Jessica C.
    Goldman, Stanton
    Barth, Matthew J.
    Shi, Qiuhu
    Klejmont, Liana
    Harrison, Lauren
    Basso, Jackie
    Chu, Yaya
    Islam, Humayun
    Gerard, Perry
    Oesterheld, Javier
    Heym, Kenneth Matthew
    Kirov, Ivan I.
    Drachtman, Richard A.
    Harker-Murray, Paul
    Perkins, Sherrie L.
    Miles, Rodney R.
    Shiramizu, Bruce
    Cairo, Mitchell S.
    BLOOD, 2020, 136
  • [42] Low level of cerebrospinal fluid (CSF) rituximab (RTX) following intravenous rituximab in children, adolescents and young adults (CAYA) with de novo mature B-cell Non-Hodgkin lymphoma (B-NHL)
    Barth, Matthew J.
    Chu, Yaya
    Goldman, Stanton C.
    Hochberg, Jessica
    Oesterheld, Javier
    Heym, Kenneth
    Harrison, Lauren
    Mahanti, Harshini
    Flowers, Allyson
    Basso, Jackie
    Cairo, Mitchell S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 47 - 47
  • [43] Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non Hodgkin's lymphoma (B-NHL) - results of the UKCCSG 9003 protocol
    Atra, A
    Gerrard, M
    Hobson, R
    Imeson, JD
    Ashley, S
    Pinkerton, CR
    BRITISH JOURNAL OF CANCER, 1998, 77 (12) : 2281 - 2285
  • [44] Mature B-Cell Lymphoma and Leukemia in Children and Adolescents-Review of Standard Chemotherapy Regimen and Perspectives
    Worch, Jennifer
    Rohde, Marius
    Burkhardt, Birgit
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2013, 30 (06) : 465 - 483
  • [45] Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report
    Delrocco, N. J.
    Loh, M. L.
    Borowitz, M. J.
    Gupta, S.
    Rabin, K. R.
    Zweidler-McKay, P.
    Maloney, K. W.
    Mattano, L. A.
    Larsen, E.
    Angiolillo, A.
    Schore, R. J.
    Burke, M. J.
    Salzer, W. L.
    Wood, B. L.
    Carroll, A. J.
    Heerema, N. A.
    Reshmi, S. C.
    Gastier-Foster, J. M.
    Harvey, R.
    Chen, I. M.
    Roberts, K. G.
    Mullighan, C. G.
    Willman, C.
    Winick, N.
    Carroll, W. L.
    Rau, R. E.
    Teachey, D. T.
    Hunger, S. P.
    Raetz, E. A.
    Devidas, M.
    Kairalla, J. A.
    LEUKEMIA, 2024, 38 (04) : 720 - 728
  • [46] Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report
    N. J. DelRocco
    M. L. Loh
    M. J. Borowitz
    S. Gupta
    K. R. Rabin
    P. Zweidler-McKay
    K. W. Maloney
    L. A. Mattano
    E. Larsen
    A. Angiolillo
    R. J. Schore
    M. J. Burke
    W. L. Salzer
    B. L. Wood
    A. J. Carroll
    N. A. Heerema
    S. C. Reshmi
    J. M. Gastier-Foster
    R. Harvey
    I. M. Chen
    K. G. Roberts
    C. G. Mullighan
    C. Willman
    N. Winick
    W. L. Carroll
    R. E. Rau
    D. T. Teachey
    S. P. Hunger
    E. A. Raetz
    M. Devidas
    J. A. Kairalla
    Leukemia, 2024, 38 : 720 - 728
  • [47] TANDEM AUTOLOGOUS ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED/REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
    Gardenswartz, A.
    Mehta, B.
    El-Mallawany, N.
    van de Ven, C.
    Hochberg, J.
    Flower, A.
    Morris, E.
    Harrison, L.
    Basso, J.
    Gerard, P.
    Ayello, J.
    Baxter-Lowe, L. A.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [48] Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL) - results of the UKCCSG 9003 protocol
    A Atra
    M Gerrard
    R Hobson
    JD Imeson
    S Ashley
    CR Pinkerton
    British Journal of Cancer, 1998, 77 : 2281 - 2285
  • [49] Preliminary results of a reduced burden of therapy trial by incorporation of rituximab and intrathecal liposomal cytarabine in children, adolescents and young adults with intermediate (FAB Group B) and high risk (FAB Group C) mature B-cell lymphoma/leukemia.
    Goldman, Stanton
    Barth, Matthew John
    Oesterheld, Javier E.
    Heym, Kenneth
    Harrison, Lauren
    Nickerson, Berkley
    El-Mallawany, Nader
    Hochberg, Jessica
    Cairo, Mitchell S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol
    A Atra
    J D Imeson
    R Hobson
    M Gerrard
    I M Hann
    O B Eden
    R L Carter
    C R Pinkerton
    British Journal of Cancer, 2000, 82 : 1396 - 1402
12345